ARCHIVES

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Three Congressmen Back Straus Demand For Single Probe

August 28, 1981

Committee Approves NDA For Tamoxifen

January 21, 1977

Reagan’s 1983 Budget Would Fund NCI Grants to 180 Payline, 26 Percent Of Approved; Indirect Costs Cut

March 5, 1982

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

October 26, 2007

Appeals Court Lifts Injunction On Federal Funding for Stem Cell Research.

September 10, 2010

For ADT Reduced Use

November 5, 2010